Search research articles
Contact Us
Filters
Showing results (791-800 of 839) with videos related to
Page
of 84
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 11, 2023
Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung Cancer
Rohit Thummalapalli, Biagio Ricciuti, Chaitanya Bandlamudi, et al.
The New England Journal of Medicine
|
April 11, 2022
Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer
Patrick M Forde, Jonathan Spicer, Shun Lu, et al.
Future Oncology (London, England)
|
February 23, 2023
Plain language summary of the CheckMate 816 study results: nivolumab plus chemotherapy given before surgery for non-small-cell lung cancer
Patrick M Forde, Jonathan Spicer, Shun Lu, et al.
JTO Clinical and Research Reports
|
October 14, 2024
Three-Year Overall Survival Outcomes and Correlative Analyses in Patients With NSCLC and High (50%-89%) Versus Very High (≥90%) Programmed Death-Ligand 1 Expression Treated With First-Line Pembrolizumab or Cemiplimab
Biagio Ricciuti, Arielle Elkrief, Jessica Lin, et al.
The New England Journal of Medicine
|
May 15, 2024
Perioperative Nivolumab in Resectable Lung Cancer
Tina Cascone, Mark M Awad, Jonathan D Spicer, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 27, 2025
Distinct Clinicogenomic Features and Immunotherapy Associations in Pulmonary Sarcomatoid Carcinoma: A Multicenter Retrospective Study
Lingzhi Hong, Alessandro Di Federico, Bolun Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 5, 2019
Immune Checkpoint Inhibitor Therapy in Patients With Preexisting Inflammatory Bowel Disease
Hamzah Abu-Sbeih, David M Faleck, Biagio Ricciuti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 16, 2022
Clonal KEAP1 mutations with loss of heterozygosity share reduced immunotherapy efficacy and low immune cell infiltration in lung adenocarcinoma
S Scalera, B Ricciuti, M Mazzotta, et al.
JCI Insight
|
October 5, 2016
Multiparametric profiling of non-small-cell lung cancers reveals distinct immunophenotypes
Patrick H Lizotte, Elena V Ivanova, Mark M Awad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 25, 2023
Clinicopathologic, Genomic, and Immunophenotypic Landscape of ATM Mutations in Non-Small Cell Lung Cancer
Biagio Ricciuti, Arielle Elkrief, Joao Alessi, et al.
Page
of 84
Search research articles
Search
Showing results (791-800 of 839) with videos related to
Sort By:
Page
of 84
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 11, 2023
Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung Cancer
Rohit Thummalapalli, Biagio Ricciuti, Chaitanya Bandlamudi, et al.
The New England Journal of Medicine
|
April 11, 2022
Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer
Patrick M Forde, Jonathan Spicer, Shun Lu, et al.
Future Oncology (London, England)
|
February 23, 2023
Plain language summary of the CheckMate 816 study results: nivolumab plus chemotherapy given before surgery for non-small-cell lung cancer
Patrick M Forde, Jonathan Spicer, Shun Lu, et al.
JTO Clinical and Research Reports
|
October 14, 2024
Three-Year Overall Survival Outcomes and Correlative Analyses in Patients With NSCLC and High (50%-89%) Versus Very High (≥90%) Programmed Death-Ligand 1 Expression Treated With First-Line Pembrolizumab or Cemiplimab
Biagio Ricciuti, Arielle Elkrief, Jessica Lin, et al.
The New England Journal of Medicine
|
May 15, 2024
Perioperative Nivolumab in Resectable Lung Cancer
Tina Cascone, Mark M Awad, Jonathan D Spicer, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 27, 2025
Distinct Clinicogenomic Features and Immunotherapy Associations in Pulmonary Sarcomatoid Carcinoma: A Multicenter Retrospective Study
Lingzhi Hong, Alessandro Di Federico, Bolun Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 5, 2019
Immune Checkpoint Inhibitor Therapy in Patients With Preexisting Inflammatory Bowel Disease
Hamzah Abu-Sbeih, David M Faleck, Biagio Ricciuti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 16, 2022
Clonal KEAP1 mutations with loss of heterozygosity share reduced immunotherapy efficacy and low immune cell infiltration in lung adenocarcinoma
S Scalera, B Ricciuti, M Mazzotta, et al.
JCI Insight
|
October 5, 2016
Multiparametric profiling of non-small-cell lung cancers reveals distinct immunophenotypes
Patrick H Lizotte, Elena V Ivanova, Mark M Awad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 25, 2023
Clinicopathologic, Genomic, and Immunophenotypic Landscape of ATM Mutations in Non-Small Cell Lung Cancer
Biagio Ricciuti, Arielle Elkrief, Joao Alessi, et al.
Page
of 84